Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR
The Prostate2003Vol. 59(1), pp. 69–76
Citations Over TimeTop 10% of 2003 papers
Mine S. Cicek, David V. Conti, Anthony P. Curran, Phillippa J. Neville, Pamela L. Paris, Graham Casey, John S. Witte
Abstract
These findings suggest that the SRD5A2 V89L variant may influence risk of developing prostate cancer, especially among men with a younger age of diagnosis or more aggressive disease.
Related Papers
- → A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue(2013)17 cited
- → Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies(2014)7 cited
- THE EXPRESSIONS OF MITOSIS REGULATIVE FACTOR STK-15 IN PROSTATE CANCER(2009)
- [Updated relationship between testosterone and prostate cancer].(2014)